US EditionPublished • loading... • Updated
Apimeds merges with MindWave, supported by $100M PIPE
Summary by ROI-NJ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Apimeds merges with MindWave, supported by $100M PIPE
Apimeds Pharmaceuticals US, Inc., a clinical-stage biotechnology company in Matawan, announced that it has merged with MindWave Innovations Inc. The merger combines Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s AI-driven Bitcoin treasury, digital asset yield generation and $NILA-powered ecosystem. The combined company integrates high-growth biotechnology and institutional digital treasury capabilities, with t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
